5-phenoxysulfonyl-1-methyl-4-nitroimidazole has been researched along with flurbiprofen in 1 studies
*Flurbiprofen: An anti-inflammatory analgesic and antipyretic of the phenylalkynoic acid series. It has been shown to reduce bone resorption in periodontal disease by inhibiting CARBONIC ANHYDRASE. [MeSH]
*Flurbiprofen: An anti-inflammatory analgesic and antipyretic of the phenylalkynoic acid series. It has been shown to reduce bone resorption in periodontal disease by inhibiting CARBONIC ANHYDRASE. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jinks, S; Millar, BC; Powles, TJ | 1 |
1 other study(ies) available for 5-phenoxysulfonyl-1-methyl-4-nitroimidazole and flurbiprofen
| Article | Year |
|---|---|
Flurbiprofen, a non-steroid anti-inflammatory agent, protects cells against hypoxic cell radiosensitizers in vitro.
Topics: Animals; Cell Survival; Cells, Cultured; Cricetinae; Cricetulus; Dose-Response Relationship, Drug; Flurbiprofen; Misonidazole; Nitrofurantoin; Nitroimidazoles; Oxygen; Propionates; Radiation-Sensitizing Agents | 1981 |